Immunohistochemically, breast cancer has been classified into four subtypes: estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), human epidermal growth factor receptor 2-positive (HER+), and triple-negative (TNBC) [10]. Here, ESR1 is linked to breast carcinoma.